QAA
- Product code
- QAA
- Device name
- Coccidioides Spp. Nucleic Acid Detection System For Respiratory Specimens
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.3376
- Medical specialty
- Microbiology
- Marketing pathway
- 510(K)
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
A Coccidioides spp. nucleic acid detection system for respiratory specimens is a qualitative test for the detection of Coccidioides spp. nucleic acids directly in clinical respiratory specimens from patients with signs and symptoms of coccidioidomycosis and suspicion of infection.
Official FDA classification page: QAA
Classification and pathway per current FDA publications. Data from openFDA (CC0).